Many scholars assume that industry meddles in scientific research in order to defend their products. But this article shows that industry meddling in science can have a variety of consequences. American food manufacturers long denied that trans fats were associated with disease. Academic scientists, government scientists, and activists in fact endorsed trans fats as a healthier alternative to saturated fats. But in 1990, a high-profile study showed that trans fats increased risk factors for heart disease more than saturated fats did. Industry funded a U.S. Department of Agriculture study that they hoped would exonerate trans fats. But the industry-funded U.S. Department of Agriculture study also indicated that trans fats increased risk factors for heart disease more than saturated fats. Industry quickly began developing trans fat alternatives. This confirms that corporations get involved in science in order to defend their products. But involvement in science can be the very means by which corporations persuade themselves to change their products.
AhrensE. H.InsullW.BlomstrandR.HirschJ.TsaltasT. T.PetersonM. L. (1957). The influence of dietary fats on serum-lipid levels in man. Lancet, 269, 943-953.
2.
AngellS. Y.SilverL. D.GoldsteinG. P.JohnsonC. M.DeitcherD. R.FriedenT. R.BassettM. T. (2009). Cholesterol control beyond the clinic: New York City’s trans fat restriction. Annals of Internal Medicine, 151, 129-134.
3.
ApplewhiteT. H. (1979). Statistical “correlations” relating trans-fats to cancer: A commentary. Federation Proceedings, 38, 2435.
4.
ApplewhiteT. H. (1981). Nutritional effects of hydrogenated soya oil. Journal of the American Oil Chemists’ Society, 58, 260-269.
5.
BailarJ. C. (1979). Dietary fat and cancer trends: A further critique. Federation Proceedings, 38, 2435.
BlumeE. (1987b). Letter to the Honorable Dan Glickman, United States House of Representatives. Washington, DC: Center for Science in the Public Interest.
8.
BlumeE. (1988). The truth about trans: Hydrogenated oils aren’t guilty as charged. Nutrition Action Healthletter, 15(2), 8-10.
9.
BraunK.KroppC. (2010). Beyond speaking truth? Institutional responses to uncertainty in scientific governance. Science, Technology & Human Values, 35, 771-782.
10.
British Nutrition Foundation Task Force on Trans Fatty Acids. (1987). Trans fatty acids. London, England: British Nutrition Foundation.
CallonM. (1998). The embeddedness of economic markets in economics. In CallonM. (Ed.), The laws of the markets (pp. 1-57). Malden, MA: Blackwell/Sociological Review.
14.
CallonM. (1999). Actor-network theory—The market test. In LawJ.HassardJ. (Eds.), Actor network theory and after (pp. 181-195). Oxford, England: Blackwell/Sociological Review.
15.
CallonM. (2007). What does it mean to say that economics is performative? In MacKenzieD. A.MuniesaF.SiuL. (Eds.), Do economists make markets? On the performativity of economics (p. 373). Princeton, NJ: Princeton University Press.
16.
CallonM.MéadelC.RabeharisoaV. (2002). The economy of qualities. Economy and Society, 31, 194-217.
17.
Center for Science in the Public Interest. (1988). Saturated fat attack. Washington, DC: CSPI.
18.
Center for Science in the Public Interest. (1994). Petition to require trans fatty acids to be combined and labeled together with saturated fatty acids and to prohibit deceptive claims for foods with significant levels of trans fatty acids. Washington, DC: FDA.
19.
Center for Science in the Public Interest. (2006). Building a Healthier America, 35th Anniversary report. Washington, DC: CSPI.
20.
ChenC.-L.TetriL. H.Neuschwander-TetriB. A.HuangS. S.HuangJ. S. (2011). A mechanism by which dietary trans fats cause atherosclerosis. Journal of Nutritional Biochemistry, 22(7), 649-655.
21.
ClevidenceB. A.JuddJ. T.SchaeferE. J.JennerJ. L.LichtensteinA. H.MuesingR. A.. . . SunkinM. E. (1997). Plasma lipoprotein (a) levels in men and women consuming diets enriched in saturated, cis-, or trans-monounsaturated fatty acids. Arteriosclerosis, Thrombosis and Vascular Biology, 17, 1657-1661.
22.
CochoyF. (2007a). A brief theory of the “captation” of publics: Understanding the market with little red riding hood. Theory, Culture & Society, 24(7-8), 203-223.
23.
CochoyF. (2007b). A sociology of market-things: On tending the garden of choices in mass retailing. Sociological Review, 55, 109-129.
24.
DeSouceyM.SchleiferD. (2010). Technique and technology in the kitchen: Comparing resistance to municipal trans fat and foie gras bans. Studies in Law, Politics, and Society, 51, 185-218.
25.
Dietary Guidelines Advisory Committee. (2010). Report of the dietary guidelines advisory committee on the dietary guidelines for Americans. Washington, DC: USDA Center for Nutrition Policy and Promotion.
26.
DuttonH. J. (1979). Hydrogenation of fats and its significance. In EmkenE. A.DuttonH. J. (Eds.), Geometrical and positional fatty acid isomers (pp. 1-16). Champaign, IL: American Oil Chemists’ Society.
27.
EmkenE. A. (1991). Do trans acids have adverse health consequences? In NelsonG. J. (Ed.), Health effects of dietary fatty acids (pp. 245-263). Champaign, IL: American Oil Chemists’ Society.
28.
EnigM.FallonS. (1998-1999). The oiling of America. Nexus, 6.
29.
EnigM.MunnR. J.KeeneyM. (1978). Dietary fat and cancer trends—A critique. Journal of the Federation of American Societies for Experimental Biology, 37, 2215-2220.
30.
FAO Food and Nutrition Paper. (2010). Fats and fatty acids in human nutrition (Vol. 91). Rome, Italy: Food and Agriculture Organization of the United Nations.
31.
Federation of American Societies for Experimental Biology. (1985). Federation of American Societies for Experimental Biology, Life Sciences Research Office Report: Health aspects of dietary trans fatty acids. Bethesda, MD: Prepared for Center for Food Safety and Applied Nutrition, Food and Drug Administration.
32.
Food and Drug Administration. (2003). Food labeling: Trans fatty acids in nutrition labeling; consumer research to consider nutrient content and health claims and possible footnote or disclosure statements; final rule or proposed rule. Silver Spring, MD: Author.
33.
FineB. (2003). Callonistics: A disentanglement. Economy and Society, 32, 478-484.
FrickelS.MooreK. (2006). Prospects and challenges for a new political sociology of science In FrickelS.MooreK. (Eds.), The new political sociology of science: Institutions, networks, and power (pp. 3-31). Madison: University of Wisconsin Press.
36.
FriendT. (1990, August16). Cholesterol: In the Spread. USA Today.
37.
HarveyK. A.ArnoldT.RasoolT.AntalisC.MillerS. J.SiddiquiR. A. (2008). Trans-fatty acids induce pro-inflammatory responses and endothelial cell dysfunction. British Journal of Nutrition, 99, 723-731.
38.
HastertR. C. (1983). Hydrogenation—A tool, not an epithet. In PerkinsE. G.VisekW. J. (Eds.), Dietary fats and health (pp. 53-69). Champaign, IL: American Oil Chemists’ Society.
39.
HausmanP. (1981). Jack Sprat’s legacy: The science and politics of fat and cholesterol. New York, NY: Richard Marek.
40.
HunterJ. E. (1992). Safety and health effects of isomeric fatty acids. In ChowC. K. (Ed.), Fatty acids in foods and their health implications (pp. 857-868). New York, NY: Marcel Dekker.
41.
International Food Information Council. (1990). Press release: Hydrogenation of vegetable oils: Perspective on Mensink/Katan Study, August 17, 1990. Washington, DC: IFIC.
42.
Institute of Medicine. (1990). Nutrition labeling: Issues and directions for the 1990s. Washington, DC: National Academies Press.
43.
JacksonR.MorrisettJ.PownallH.GottoA. M.Jr.KamioA.ImaiH.. . . KummerowF. A. (1977). Influence of dietary trans-fatty acids on swine lipoprotein composition and structure. Journal of Lipid Research, 18, 182-190.
44.
JacobsonM. F. (2004). Good riddance to trans!Nutrition Action Healthletter, 31(5), 2.
45.
JacobsonM. F.FritschnerS. (1986). The fast-food guide: What’s good, what’s bad, and how to tell the difference. New York, NY: Workman.
46.
JohnstonP. V.JohnsonO. C.KummerowF. A. (1957). Non-transfer of trans fatty acids from mother to young. Proceedings of the Society for Experimental Biology and Medicine, 96, 760-762.
47.
JuddJ. T.BaerD. J.ClevidenceB. A.MuesingR. A.ChenS. C.WeststrateJ. A.. . . SchaeferE. J. (1998). Effects of margarine compared with those of butter on blood lipid profiles related to cardiovascular disease risk factors in normolipemic adults fed controlled diets. American Journal of Clinical Nutrition, 68, 768-777.
48.
JuddJ. T.ClevidenceB. A.MuesingR. A.WittesJ.SunkinM. E.PodczasyJ. J. (1994). Dietary trans fatty acids: Effects on plasma lipids and lipoproteins of healthy men and women. American Journal of Clinical Nutrition, 59, 861-868.
49.
KesslerD. A. (2001). A question of intent: A great American battle with a deadly industry. New York, NY: Public Affairs.
50.
KirkmanR. (2009). At home in the seamless web: Agency, obduracy, and the ethics of metropolitan growthScience, Technology & Human Values, 34, 234-258.
51.
KrimskyS. (2003). Science in the private interest: Has the lure of profits corrupted biomedical research?Lanham, MD: Rowman & Littlefield.
52.
KritchevskyD. (1958). Cholesterol. New York, NY: Wiley.
53.
KritchevskyD. (1983). Influence of trans unsaturated fat on experimental atherosclerosis. In PerkinsE. G.VisekW. J. (Eds.), Dietary fats and health (pp. 403-413). Champaign, IL: American Oil Chemists’ Society.
54.
KummerowF. A. (1965). Metabolism of lipids as related to atherosclerosis: A symposium. Springfield, IL: Thomas.
55.
KummerowF. A. (1979). Effects of isomeric fats on animal tissue, lipid classes and atherosclerosis. In EmkenE. A.DuttonH. J. (Eds.), Geometrical and positional fatty acid isomers (pp. 151-180). Champaign, IL: American Oil Chemists’ Society.
56.
KummerowF. A. (1986). Dietary effects of trans fatty acids. Journal of Environmental Pathology, Toxicology and Oncology, 6(3-4), 123-149.
57.
KummerowF. A.MizuguchiT.ArimaT.YehS. C.ChoB. (1978). The influence of three sources of dietary fats and cholesterol on lipid composition of swine serum lipids and aorta tissue. Artery, 4, 360-384.
58.
KummerowF. A.MizuguchiT.ArimaT.YehS. C.ChoB.TracyR. (1974). Swine as an animal model in studies on atherosclerosis. Federation Proceedings, 33, 183.
59.
LatourB. (1992). Where are the missing masses? The sociology of a few mundane artifacts. In BijkerW. E.LawJ. (Eds.), Shaping technology/building society: Studies in sociotechnical change (pp. 225-258). Cambridge: MIT Press.
60.
LatourB. (1999). Give me a laboratory and I will raise the world. In BiagioliM. (Ed.), The science studies reader (pp. 258-276). New York, NY: Routledge.
61.
LesserL. I.EbbelingC. B.GooznerM.WypijD.LudwigD. S. (2007). Relationship between funding source and conclusion among nutrition-related scientific articles. PLoS Medicine, 4(1), 0041-0046.
62.
LiebmanB. (1990). Trans in trouble. Nutrition Action Healthletter, 17(8), 7.
63.
ListG.KritchevskyD.RatnayakeW. M. N. (2007). Trans fats in foods. Urbana, IL: AOCS Press.
64.
MarkowitzG. E.RosnerD. (2002). Deceit and denial: The deadly politics of industrial pollution. Berkeley: University of California Press.
65.
MattsonF. H.HollenbachE.KligmanA. (1975). Effect of hydrogenated fat on the plasma cholesterol and triglyceride levels of manAmerican Journal of Clinical Nutrition, 28, 726-731.
66.
McFallL. (2009). Devices and desires: How useful is the “new” new economic sociology for understanding market attachment?Sociology Compass, 3, 267-282.
67.
MensinkR.KatanM. (1990). Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol in healthy subjects. New England Journal of Medicine, 323, 439-445.
68.
MensinkR.ZockP.KatanM.HornstraG. (1992). Effect of dietary cis and trans fatty acids on serum lipoprotein[a] levels in humans. Journal of Lipid Research, 33, 1493-1501.
69.
MeyerW. H. (1979). Further comments. Federation Proceedings, 38, 2436.
70.
MichaelsD. (2008). Doubt is their product: How Industry’s assault on science threatens your health. New York, NY: Oxford University Press.
71.
National Research Council. (1989). Diet and health: Implications for reducing chronic disease risk. Washington, DC: National Academies Press.
72.
NestleM. (2001). Food company sponsorship of nutrition research and professional activities: A conflict of interest?Public Health Nutrition, 4, 1015-1022.
73.
NestleM. (2002). Food politics: How the food industry influences nutrition and health. Berkeley: University of California Press.
74.
New York Times. (1990, August16). Margarine’s bad side exposed. Study: It’s better than butter, but it puts heart at risk. Chicago Tribune.
75.
PendersB.NelisA. (2011). Credibility engineering in food industry: Linking science and marketing in a corporate context. Science in Context24(4), 487-515.
76.
Progressive Grocer. (2010, August30). More than 20,000 healthier products introduced since 2002: GMA study. Deerfield IL: Stagnito Media.
77.
ReevesR. (1991). Letter to the editor. New England Journal of Medicine, 324, 338-339.
78.
ResnikD. B. (2007). The price of truth: How money affects the norms of science. New York, NY: Oxford University Press.
79.
RiepmaS. F. (1970). The story of margarine. Washington, DC: Public Affairs Press.
80.
RosnerD.MarkowitzG. E. (1991). Deadly dust: Silicosis and the politics of occupational disease in twentieth-century America. Princeton, NJ: Princeton University Press.
81.
RoyceS.HolmesR.TakagiT.KummerowF. (1984). The influence of dietary isomeric and saturated fatty acids on atherosclerosis and eicosanoid synthesis in swine. American Journal of Clinical Nutrition, 39, 215-222.
82.
Sánchez-VillegasA.VerberneL.IralaJ. D.Ruíz-CanelaM.ToledoE.Serra-MajemL.Martínez-GonzálezM. A. (2011). Dietary fat intake and the risk of depression: The SUN Project. PLoS ONE, 6(1), e16268.
83.
SchleiferD. (2010). Reforming food: How trans fats entered and exited the American Food System (Unpublished doctoral dissertation). New York University, NY.
84.
SchleiferD. (2012). The perfect solution: How trans fats became the healthy replacement for saturated fats. Technology and Culture53(1).
85.
SchurmanR. (2004). Fighting “Frankenfoods”: Industry opportunity structures and the efficacy of the anti-biotech movement in Western Europe. Social Problems, 51, 243-268.
86.
SimonM. (2006). Appetite for profit: How the food industry undermines our health and how to fight back. New York, NY: Nation Books.
87.
SismondoS. (2008). Pharmaceutical company funding and its consequences: A qualitative systematic review. Contemporary Clinical Trials, 29, 109-113.
88.
SismondoS. (2011). Corporate disguises in medical science: Dodging the interest repertoire. Bulletin of Science, Technology and Society, 31(6), 482–492.
89.
SokolofP. (1990). The poisoning of America III. Advertisement in the New York Times.
VogelD. (2005). The market for virtue: The potential and limits of corporate social responsibility. Washington, DC: Brookings Institution Press.
92.
WatkinsC. (2008). North American vegetable oil use in flux. Inform, 19, 493.
93.
WeinraubJ. (2003, November12). Getting the fat out. Washington Post, p. F01.
94.
WhittleA.SpicerA. (2008). Is actor network theory critique?Organization Studies, 29, 611-629.
95.
WillettW.AscherioA. (1994). Trans fatty acids: Are the effects only marginal?American Journal of Public Health, 84, 722-724.
96.
WillettW.StampferM. J.MansonJ. E.ColditzG. A.SpeizerF. E.RosnerD.HennekensC. H. (1993). Intake of trans fatty acids and risk of coronary heart disease among women. Lancet, 341, 581-585.
97.
WinnerL. (1980). Do artifacts have politics?Daedalus, 109(1), 121-136.
98.
WootanM.LiebmanB. (1993). The great trans wreck. Nutrition Action Healthletter, 20, 10-13.
